Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
Document Type
Journal Article
Publication Date
10-1-2014
Journal
The pharmacogenomics journal
Volume
14
Issue
5
Inclusive Pages
473-80
DOI
10.1038/tpj.2014.14
Keywords
Anticonvulsants--adverse effects; Asian Continental Ancestry Group--genetics; Carbamazepine--adverse effects; HLA-B15 Antigen--genetics; United States Food and Drug Administration--legislation & jurisprudence
APA Citation
Payne, P. W. (2014). Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct? The Pharmacogenomics Journal, 14(5): 473–480. doi: 10.1038/tpj.2014.14.
Peer Reviewed
1
COinS